Jaju Pharmaceuticals Private Limited
About Jaju Pharmaceuticals Private Limited
Data last updated:
Jaju Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 September 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24231DL2002PTC117013. Its GSTIN is 09AABCJ1769P1ZX (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹7.86 Lakh. It is led by directors including Pramod Kumar Jaju and Saurabhraj Jaju.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 6/51 Unit 23 GF Tribhuvan Complex Ishwar Nagar Mathura, Road, New Delhi, Delhi, India – 110065.
As per the financials filed for FY 2025, the company reported a revenue of ₹11.82 Cr, a growth of 33% compared to the previous year. For the same year it recorded a net profit of ₹19.37 Lakh (net margin 1.6%) and EBITDA of ₹44.33 Lakh (EBITDA margin 3.8%). Revenue has grown at a compounded annual rate (CAGR) of 30% over three years and 23% over five years.
As per MCA filings, the company has open charges of ₹11 Lakh and satisfied charges of ₹9.5 Lakh on record. Court records list 3 cases involving the company, including 2 filed by the company and 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Jaju Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No. 6/51 Unit 23 GF Tribhuvan Complex Ishwar Nagar Mathura, Road, New Delhi, Delhi, India – 110065
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Jaju Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Jaju Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Jaju Pharmaceuticals Private Limited, buy the company report.
Financials of Jaju Pharmaceuticals Private Limited
FY 2025 filings availableJaju Pharmaceuticals Private Limited reported revenue of ₹11.82 Cr (up 33% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 23% over five years, including 33% growth in the latest year. EBITDA rose 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹44.33 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹19.37 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.8% | ||||
| Net Profit Margin | 1.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Jaju Pharmaceuticals Private Limited, buy the company report.
Board of directors of Jaju Pharmaceuticals Private Limited
Jaju Pharmaceuticals has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pramod Kumar Jaju Also directs: Shri Govind Kripa Builders and Promoters Private Limited | Director | 17 Sep 2002 | 24 Years 1 Months | Current |
| Saurabhraj Jaju Also directs: Shri Govind Kripa Builders and Promoters Private Limited, Om Shankh Naad Entt LLP, Purnaakriti Constructions LLP and 1 more | Director | 17 Sep 2002 | 24 Years 1 Months | Current |
| Saharsh Jaju Also directs: SFC Beverages Private Limited | Director | 01 Apr 2024 | 2 Years 6 Months | Current |
| Pooja Jaju | Director | 05 Aug 2024 | 2 Years 2 Months | Current |
Peer comparison
Jaju Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Tidal Laboratories Private Limited | ₹11.87 Cr (FY 2025) | 34.0% | Mumbai, Maharashtra, India | |||
| Jaju Pharmaceuticals Private Limitedthis company | ₹11.82 Cr (FY 2025) | ₹19.37 Lakh | 1.6% | 33.0% | New Delhi, Delhi, India | |
| Rups Medipack Private Limited | ₹11.81 Cr (FY 2025) | 52.0% | New Delhi, Delhi, India | |||
| Himsagar Laboratories Limited | ₹11.79 Cr (FY 2025) | 1.0% | New Delhi, Delhi, India | |||
| Vadish Pharma Private Limited | ₹11.79 Cr (FY 2025) | 12.0% | Mehsana, Gujarat, India |
To see the full peer comparison of Jaju Pharmaceuticals Private Limited, buy the company report.
Auditor
Jaju Pharmaceuticals Private Limited is audited by SANJEEV KIRAN & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SANJEEV KIRAN & CO | FY 2022 | 007024N |
Shareholding
The shareholding of Jaju Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Jaju Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Mar 2010 | 10216291 | Punjab National Bank | ₹6 Lakh | Open | |
| 29 Mar 2010 | 10216302 | Punjab National Bank | ₹5 Lakh | Open | |
| 17 Nov 2003 | 90038506 | Punjab National Bank | ₹9.5 Lakh | Satisfied |
To see the full charge records of Jaju Pharmaceuticals Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Jaju Pharmaceuticals Private Limited has 3 court cases on record: 2 filed by Jaju Pharmaceuticals, 1 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 1 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South East, Delhi | Commercial suit | Filed by the company against an individual | Disposed |
| District court, Budaun, Uttar Pradesh | Criminal case | Filed against the company by State Government | Disposed |
| District court, Central, Delhi | Criminal case | Filed by the company against individuals | Disposed |
To see the full case history of Jaju Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Jaju Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Jaju Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AABCJ1769P1ZX | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Jaju Pharmaceuticals Private Limited, buy the company report.
Recent activity
Jaju Pharmaceuticals Private Limited has 6 board changes on record since 2002: 4 appointments and 2 cessations. The latest: Pooja Jaju ceased to be Additional Director on 29 Sep 2025.
1 earlier event is in the company report.
Frequently asked questions
Jaju Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 September 2002 (24+ years old) and is registered under CIN U24231DL2002PTC117013.
Jaju Pharmaceuticals has 4 current directors:
- Pramod Kumar Jaju - Director
- Saurabhraj Jaju - Director
- Saharsh Jaju - Director
- Pooja Jaju - Director
The latest financial statements of Jaju Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Jaju Pharmaceuticals is 09AABCJ1769P1ZX, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Jaju Pharmaceuticals is U24231DL2002PTC117013. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Jaju Pharmaceuticals has 3 court cases on record: 2 filed by the company and 1 filed against it.
Jaju Pharmaceuticals was incorporated on 17 September 2002, making it 24+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Jaju Pharmaceuticals by revenue are Tidal Laboratories Private Limited, Rups Medipack Private Limited, Himsagar Laboratories Limited, Vadish Pharma Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Pooja Jaju ceased to be Additional Director on 29 Sep 2025. Saharsh Jaju ceased to be Additional Director on 29 Sep 2025. Pooja Jaju was appointed as Director on 05 Aug 2024. Jaju Pharmaceuticals has 6 board changes on record in total.
The registered office of Jaju Pharmaceuticals is at Plot No. 651 Unit 23 GF Tribhuvan Complex Ishwar Nagar Mathura, Road, New Delhi, Delhi, India – 110065.
Jaju Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.